Poster walk, Thursday - Risk-Based/Personalized Screening 1
Tracks
Thursday, June 19, 2025 |
12:45 - 14:00 |
Smedien, Centralvaerkstedet |
Speaker(s)
Dr Paula Berstad
Senior Researcher
Norwegian Institute of Public Health
008 - The association between alcohol consumption and colorectal carcinogenesis is partially mediated by the gut microbiome
Biography
Dr. Paula Berstad, PhD, is a senior researcher at the Cancer Registry of Norway, the Norwegian Institute for Public Health. She focuses on cancer prevention, particularly colorectal cancer screening. Her research explores integrating lifestyle assessments into screening to improve risk stratification and personalized prevention. She also studies the interaction between the gut microbiome and lifestyle factors in colorectal cancer development, as well as barriers to screening participation, emphasizing disparities in immigrant populations.
Dr Paula Berstad
Senior Researcher
Norwegian Institute of Public Health
309 - Change in lifestyle after colonoscopy screening in relation to incidence of colorectal cancer and major chronic diseases in 3 US population-based cohorts
Biography
I'm a post doc, and have for several years worked within lifestyle and personalized CRC screening and how colorectal cancer screening can be used for primary and secondary prevention. I have investigated this in several Norwegian projects and also been working closely with associated professor Mingyang Song at Harvard T.H. Chan School of Public Health. Within this collaboration I have used the Nurses Health Study I and II along with the Health Professional Follow-up study cohorts.
Mr Siebe Dibbets
PhD Student
Erasmus MC
271 - The optimal upper age limit for breast cancer screening, accounting for differences in comorbidity status and smoking behaviour
Biography
I am Siebe Dibbets, a PhD candidate in Public Health at Erasmus Medical Centre, with a background in Health Economics and Management. My research focuses on the economic evaluation of breast cancer screening in the Netherlands, aiming to improve decision-making in healthcare. I am passionate about using data-driven approaches to create meaningful impact in public health policy. Beyond my academic pursuits, I enjoy staying active through fitness, exploring the world through travel, and continuously seeking personal growth. I strive to bring energy, curiosity, and a commitment to excellence to everything I do, both in and out of my professional life.
Mr Eugenio Quessep Gil
Phd Candidate
Erasmus MC
246 - Simulation of a personalized breast cancer screening strategy: comparison with a one-size-fits-all approach across subgroups varying by risk and density
Biography
PhD candidate at the department of Public Health at the Erasmus MC since February 2022, focused on modelling and evaluation of risk-based screening strategies for breast cancer.
Mr Aapeli Nevala
Development Manager
Finnish Cancer Registry
300 - When you got nothing but time --- a novel Bayesian method for risk-prediction using prospective colorectal cancer screening data
Biography
Development manager at Finnish Cancer Registry, focusing on development of data collection and reporting, especially on colorectal cancer screening programme. As a researcher building statistical models for real-world scenarios where data is unobserved, misclassified and observed in time -- that is cancer screening.
Dr Ekaterina Plys
Scientific Collaborator
Unisanté
306 - Colorectal cancer screening based on predicted risk: a randomized controlled trial
Biography
After obtaining her PhD in Psychology from the University of Geneva in 2019, Ekaterina Plys has been working as a research associate specializing in colorectal cancer screening.
Dr Ekaterina Plys
Scientific Collaborator
Unisanté
305 - Effectiveness of risk-based recommendations for colorectal cancer screening to detect advanced neoplasia: protocol for a randomized controlled trial
Biography
After obtaining her PhD in Psychology from the University of Geneva in 2019, Ekaterina Plys has been working as a research associate specializing in colorectal cancer screening.
Dr Francesco Venturelli
Md, Phd
Epidemiology Unit, Azienda USL-IRCCS Di Reggio Emilia, Italy
315 - Risk-based cervical cancer screening: from evidence generation to the development of Italian recommendations on the use of biomarkers in screening programmes.
Biography
MD, PhD, working at the Epidemiology unit of the Cancer Research Centre of Reggio Emiilia, Italy. He is involved in guidelines development processes on cervical andbreast cancer screening. He is also involved in research projects of risk-based screening.
Chair(s)
Søren Egstrand
MD, Phd
Herlev and Gentofte Hospital
